Elephas Biosciences
PrivateLast Round
Series B
Extension
Nov 6, 2025
Total Funding Raised
$212.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elephas Biosciences is a biotechnology company that develops a precision oncology platform utilizing artificial intelligence and advanced 3D imaging to test live patient tumor biopsies against potential therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elephas Biosciences Comparables
Compare Elephas Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Farcast Biodynamics | 84% | |
| Kiyatec | 79% | |
| Xsphera Biosciences | 79% |
Elephas Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Nov 6, 2025 | ||||
| Series C | Jan 23, 2024 | ||||
| Series B | Sep 6, 2022 | ||||
| Series A | Oct 14, 2021 | ||||
| Series A | Sep 15, 2021 | ||||
Seed | Apr 1, 2020 |
Key People
Founding team and executive leadership
Elephas Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ARCH Venture Partners | Series B Extension, Series C, Series B |
| WARF Ventures | Series A, Series C, Series B |
| State of Wisconsin Investment Board | Series B Extension, Series C |
| Northpond Ventures | Series B Extension, Series C, Series B |
| Moore Strategic Ventures | Series C, Series B |
| Venture Investors Health Fund | Series B Extension, Series C |
| ARCH Venture Partners | Series B Extension, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Grew 16% QoQ, from 141 to 163 employees.
- Apr 15, 2026
Partnering with Mithrl to accelerate research using their AI platform.
Recent news
Latest coverage and updates
- attends_eventOct 6, 2026
Elephas attends SITC 2026 in Arizona on Nov 4th–8th '26
- partners_withSep 24, 2026
Elephas partnered with Tes Pharma S.r.l. on Sep 24th '26.
- partners_withAug 13, 2026
Elephas partnered with Neuberg Diagnostics on Aug 13th '26.
- is_developingJul 30, 2026
Elephas is developing approach to immunotherapy testing on Jul 1st '20.
- attends_eventJul 24, 2026
Elephas attended event American Association for Cancer Research Drug Discovery and Development (AACR D3) conference on Jul 24th '26.
Elephas Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elephas Biosciences's valuation, stock price, and market status.
Is Elephas Biosciences a public or private company?
Elephas Biosciences is a private company.
What is the current stock price of Elephas Biosciences?
Elephas Biosciences is a private company, so its shares have no public market price. Caplight tracks Elephas Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Elephas Biosciences worth (valuation)?
Valuation information for Elephas Biosciences is not publicly available.
Can I buy Elephas Biosciences stock?
Elephas Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Elephas Biosciences's last funding round?
Elephas Biosciences's most recent funding round was Series B Extension on November 6, 2025.
Who are the main investors in Elephas Biosciences?
Key investors in Elephas Biosciences include ARCH Venture Partners, State of Wisconsin Investment Board, Venture Investors Health Fund, ARCH Venture Partners, Venture Investors LLC.
Will Elephas Biosciences IPO soon?
No public IPO plans have been announced for Elephas Biosciences.
How can I track Elephas Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Elephas Biosciences's shares on secondary markets.